سعر كيموكارب 10 مجم / مل 450 مجم فيال 2023

Kemocarb carboplatin 10 mg/mL solution, 450 mg vial for intravenous infusion (Fresenius Kabi; distributed in Egypt by Egyptian Group for Import and Export).

• Initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents (e.g. with cyclophosphamide).DailyMed (U.S. National Library of Medicine)
• Palliative treatment of ovarian carcinoma recurrent after prior chemotherapy, including patients previously treated with cisplatin.DailyMed (U.S. National Library of Medicine)

• Bone marrow suppression (leukopenia, neutropenia, thrombocytopenia, cumulative anemia), nausea and vomiting, allergic reactions, peripheral neuropathy, ototoxicity and electrolyte changes are described in the label.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• History of severe allergic reactions to cisplatin or other platinum-containing compounds.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Severe bone marrow depression or significant bleeding.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: give only under the supervision of a physician experienced in cancer chemotherapy; bone marrow suppression is dose-related and may be severe (infection, bleeding); anemia may be cumulative; vomiting is frequent; anaphylactic-like reactions may occur within minutes of administration.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Peripheral neurotoxicity is more frequent in patients over 65 years and those previously treated with cisplatin; loss of vision has been reported with higher than recommended doses; high doses have caused severe liver test abnormalities.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• AminoglycosidesConcomitant aminoglycosides have resulted in increased renal and/or audiologic toxicity; use caution.DailyMed (U.S. National Library of Medicine)
• Nephrotoxic compoundsThe renal effects of nephrotoxic compounds may be potentiated by carboplatin.DailyMed (U.S. National Library of Medicine)

• Carboplatin may cause fetal harm when given to a pregnant woman; it is embryotoxic and teratogenic in rats and there are no adequate studies in pregnant women.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• It is not known whether carboplatin is excreted in human milk; breast-feeding should be discontinued during treatment.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Carboplatin: Platinum compound that forms DNA cross-links, interfering with DNA replication and cell division.